FindTrial
Sign In

Effective of Larveel® in patient with chronic wound healing

Effective of Larveel® in patient with chronic wound healing

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180220002
Enrollment
12
Registered
2018-02-20
Start date
2017-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic wound is mean wound are not cure in 4 weeks Larveel MDT Maggot therapy Lyophilized of the larva

Interventions

Lyophilized extract of the larva Lucilia sericata
Experimental Drug
Larveel

Sponsors

Faculty of Medicine, Khon Kaen University
Lead Sponsor
Alpha&#45
Collaborator
Biocare GmbH&#44
Collaborator
University of Duesseldorf
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of chronic wound 2. consent for eperiment 3. going to amputation 4. limited with other procedure, such as anesthesia 5. limeted for close the wound, such as bed ridden, can not prone postition

Exclusion criteria

Exclusion criteria: 1. Denide traial 2. Ampuatated for standard saved life

Design outcomes

Primary

MeasureTime frame
50 percent of sample size to improve wound in 6 weeks 6 weeks size of wound—

Secondary

MeasureTime frame
Factor for wound healing 6 weeks Count—

Countries

Thailand

Contacts

Public ContactKamolwan Janewitheesuk

Faculty of medicine, Khon Kaen University

Kamoje@kku.ac.th081-545-2198

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026